RODRIGUEZ RAUL R 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 28, 2025
Insider Transaction Report
Form 4
RODRIGUEZ RAUL R
DirectorCEO, President
Transactions
- Exercise/Conversion
Common Stock
2025-01-24$21.40/sh+45,000$963,000→ 250,584 total - Exercise/Conversion
Common Stock
2025-01-24$21.40/sh+45,000$963,000→ 249,662 total - Tax Payment
Common Stock
2025-01-24$22.17/sh−44,078$977,209→ 205,584 total - Tax Payment
Common Stock
2025-01-24$22.17/sh−44,078$977,209→ 206,506 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-24−45,000→ 0 totalExercise: $21.40From: 2016-04-04Exp: 2025-01-26→ Common Stock (45,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-24−45,000→ 0 totalExercise: $21.40Exp: 2025-01-26→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F2]Includes 1,000 shares acquired under the Issuer's stock purchase plan.
- [F3]The shares vested monthly over two (2) years from January 1, 2015.